PST OsteoT - General Information

204 million people worldwide suffer from osteoporosis

Over 200 million women and 4 million men around the world suffer from bone loss (osteoporosis). The majority, however, believe they will not be affected by this disease.
A survey conducted by the International Osteoporosis Foundation (IOF) showed that eight in ten women do not consider themselves as being at risk. In reality however, this is not the case. Every third woman suffers from osteoporosis. In men, the prevalence is becoming increasingly more frequent. According to the World Health Organisation (WHO), after cardiovascular diseases, osteoporosis is one of the world's greatest health-related problems

Worldwide, every third women and ever eighth man over 50, is in danger of suffering a fracture as a result of osteoporosis. Due to the increase in life expectancy, the number of hip fractures is expected to increase from 1,7 million in 1990, to approximately 6,3 million in 2050.

Osteoporosis is a disease associated with bone loss. In a healthy adult, a balance is maintained between the rate of formation and resorption. In osteoporosis, this balance is disturbed - either too little bone forms or too much is resorbed. Consequently, the bone becomes porous and brittle. Vertebral and femur fractures are the most common types of fractures.

Today, osteoporosis is one of the most prevalent metabolic bone disorders. It primarily affects women during and after menopause, but is increasingly becoming more prevalent among men.

It results in weak, brittle bones, constant pain, enforced immobility, and progressive loss of mechanical resilience, ultimately leading to immobilization. This in turn affects both circulatory and respiratory functions, and increases the fear of future fractures.

PST OsteoT - Causes
Women are more prone to suffer from Osteoporosis than men, due to the decrease in estrogen levels (a key hormone in bone maintenance), with menopause. It is believed that four times as many women, as men, are affected.

Important risks for both men and women are:

Hormonal disorders, diseases of the intestinal tract, liver and kidneys, as well as cancer, may trigger Osteoporosis (so-called secondary Osteoporosis).
Decreased testicular (functional) activity (so-called hypogonadism) can lead to Osteoporosis in men.

PST OsteoT - Therapy

Each therapy course consists of twelve, 60-minute, treatments administered on consecutive working days. Treatment is generally only interrupted over the weekend. The vertebral column, shoulder blades and pelvis are simultaneously treated.
Patients with Osteoporosis and other musculoskeletal disorders have the added benefit that the entire upper body is simultaneously treated! Some patients may experience a slight tingling, or warm sensation during treatment, and initially, may experience a transient change in the nature, or intensification, of the pain, but this is only considered a positive tissue response to PSTT.

Both bone and cartilage are connective tissue types and essentially closely related.

Trabecular bone turnover rate is significantly higher than that of cortical bone (the outer bone layer). As a result, in Osteoporosis, the initial decrease in bone mineral density is observed in trabecular bone. A well-defined microarchitecture is therefore pertinent for bone strength and stability, as cross-links significantly increase the maximum load-bearing capacity in the largely hollow space within bone (comparable to a scaffold).